Vapotherm (NYSE:VAPO) Announces Earnings Results, Beats Estimates By $0.05 EPS
Vapotherm (NYSE:VAPO) posted its quarterly earnings data on Monday. The company reported ($0.76) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.05, Morningstar.com reports. Vapotherm updated its FY 2019 guidance to EPS.
NYSE:VAPO opened at $19.20 on Tuesday. The firm has a fifty day moving average price of $20.31. Vapotherm has a 1-year low of $14.70 and a 1-year high of $24.63. The company has a current ratio of 6.35, a quick ratio of 5.34 and a debt-to-equity ratio of 1.01. The stock has a market cap of $342.88 million and a price-to-earnings ratio of -1.39.
Separately, Zacks Investment Research lowered shares of Zai Lab from a “buy” rating to a “hold” rating in a research report on Saturday, June 15th. One investment analyst has rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $26.50.
Vapotherm Company Profile
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Recommended Story: What does an equal weight rating mean?
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.